| 000 | 01632cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030303.0 | ||
| 008 | 101002s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2010.Re.P | ||
| 100 | 0 | _aRehab Ahmed Abdelmonem Hassan | |
| 245 | 1 | 2 |
_aA pharmaceutical study on carvedilol / _cRehab Ahmed Abdelmonem Hassan ; Supervised Mohamed Ahmed Elnabarawi , Amna Mohamed Awadallah Makky , Iman Saad Ahmed |
| 246 | 1 | 5 | _aدراسة صيدلية على عقار الكارفيديلول |
| 260 |
_aCairo : _bRehab Ahmed Abdelmonem Hassan , _c2010 |
||
| 300 |
_a237P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aOur purpose was modifying Carvedilol solubility and dissolution . That may cause problems of irregular bioavailability . Carvedilol binary solid dispersions were prepared by solvent evaporation method using various polymers namely ; PEG 4000, PEG 6000, PVP K90, HPMC in comparison to Inutec SP1 at three different drug to polymer ratio ( 1:1, 1:2 and 1:4 ) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCarvedilol | |
| 653 | 4 | _aHypertension | |
| 653 | 4 | _aOrodispersible tablets | |
| 700 | 0 |
_aAmna Mohamed Awadallah Makky , _eSupervisor |
|
| 700 | 0 |
_aIman Saad Ahmed , _eSupervisor |
|
| 700 | 0 |
_aMohamed Ahmed Elnabarawi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c31562 _d31562 |
||